Barclays PLC Pfizer Inc Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Pfizer Inc stock. As of the latest transaction made, Barclays PLC holds 18,545,558 shares of PFE stock, worth $465 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
18,545,558
Previous 3,234,900
473.3%
Holding current value
$465 Million
Previous $78.4 Million
502.62%
% of portfolio
0.06%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding PFE
# of Institutions
3,356Shares Held
3.57BCall Options Held
86.1MPut Options Held
105M-
Vanguard Group Inc Valley Forge, PA534MShares$13.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA299MShares$7.5 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA129MShares$3.24 Billion0.22% of portfolio
-
Morgan Stanley New York, NY74.8MShares$1.88 Billion0.12% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...